Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Pancreatic Neoplasms 5Motor Activity 3Colonic Neoplasms 3Prostatic Neoplasms 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Pancreatic Adenocarcinoma 1Muscular Diseases 1Head and Neck Neoplasms 1Gastric Adenocarcinoma 1Cholangiocarcinoma 1Cachexia 1Breast Neoplasms 1

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 46pembrolizumab 35Fluorouracil 33Capecitabine 31durvalumab 27Leucovorin 27lenvatinib 26Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Resistance Training × Gastrointestinal × Clear all
NCT05921552 2025-12-04

Senior Adult Hepatobiliary Prehab Study

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Active not recruiting
25 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡